Welcome to our dedicated page for Bridgewater Banc SEC filings (Ticker: BWBBP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BWBBP SEC filings page focuses on regulatory documents for Bridgewater Bancshares, Inc. that are relevant to its 5.875% Non-Cumulative Perpetual Preferred Stock, Series A, and the associated depositary shares trading as BWBBP on Nasdaq. As the parent company of Bridgewater Bank and a Minnesota-based savings institution, Bridgewater Bancshares, Inc. files periodic and current reports with the U.S. Securities and Exchange Commission that describe its financial condition, capital structure, and material events.
Investors researching BWBBP can use this page to access Forms 10-K and 10-Q, which provide comprehensive discussions of net interest income, net interest margin on a fully tax-equivalent basis, loan and deposit balances, asset quality ratios, and capital levels. These filings help readers evaluate the issuer’s capacity to support its preferred and common equity over time.
Current reports on Form 8-K offer additional detail on specific events that may matter for BWBBP holders. For example, the Company has filed 8-Ks describing the declaration of quarterly cash dividends on the 5.875% Non-Cumulative Perpetual Preferred Stock, Series A, including the equivalent amount per BWBBP depositary share. Other 8-Ks have outlined the entry into a Subordinated Note Purchase Agreement and the issuance of 7.625% Fixed-to-Floating Rate Subordinated Notes due 2035, the extension of a stock repurchase program for common stock, and executive leadership changes.
On Stock Titan, these filings are updated in near real time as they are made available on EDGAR. AI-powered summaries highlight key points from lengthy documents, helping users quickly identify disclosures related to preferred dividends, capital instruments, and board or management actions. The page also provides convenient access to other filing types, such as Form 4 insider transaction reports and proxy statements, so investors can see how insider activity and governance decisions intersect with the capital structure that includes BWBBP.
BWB filed a Form 144 notice to sell 20,000 shares. The notice lists prior sales of 9,838 shares on 02/06/2026 for $185,840.80. Shares outstanding were 27,832,867 as of 04/29/2026, and the planned sale is reported as a Company Issuance for cash.
BWB filed a Form 144 notice to sell 20,000 shares. The notice lists prior sales of 9,838 shares on 02/06/2026 for $185,840.80. Shares outstanding were 27,832,867 as of 04/29/2026, and the planned sale is reported as a Company Issuance for cash.
Bridgewater Bancshares, Inc. reported strong first quarter 2026 results, with net income of $17.4 million, up from $13.3 million in the prior quarter and $9.6 million a year earlier. Diluted EPS rose to $0.58 from $0.43 and $0.31 in those periods.
Net interest margin improved to 2.99% from 2.75% in Q4 2025 and 2.51% in Q1 2025, helped by lower funding costs and a gain on securities sales. Net interest income increased to $36.6 million, while noninterest income rose sharply to $9.6 million, driven largely by a $7.3 million gain on securities.
Total gross loans reached $4.37 billion, growing 5.5% annualized from year-end 2025 and 8.7% year over year. Total deposits were $4.31 billion, slightly below Q4 2025 but up 3.4% from Q1 2025. Asset quality remained solid, with nonperforming assets at 0.22% of total assets and annualized net charge-offs at 0.05% of average loans.
Shareholders’ equity increased to $528.4 million, and tangible book value per share rose to $15.93. The company launched an at-the-market equity program for up to $50 million of common stock and declared a quarterly dividend on its 5.875% Series A preferred stock of $36.72 per share, or $0.3672 per depositary share, payable June 1, 2026 to holders of record on May 15, 2026.
Bridgewater Bancshares, Inc. reported strong first quarter 2026 results, with net income of $17.4 million, up from $13.3 million in the prior quarter and $9.6 million a year earlier. Diluted EPS rose to $0.58 from $0.43 and $0.31 in those periods.
Net interest margin improved to 2.99% from 2.75% in Q4 2025 and 2.51% in Q1 2025, helped by lower funding costs and a gain on securities sales. Net interest income increased to $36.6 million, while noninterest income rose sharply to $9.6 million, driven largely by a $7.3 million gain on securities.
Total gross loans reached $4.37 billion, growing 5.5% annualized from year-end 2025 and 8.7% year over year. Total deposits were $4.31 billion, slightly below Q4 2025 but up 3.4% from Q1 2025. Asset quality remained solid, with nonperforming assets at 0.22% of total assets and annualized net charge-offs at 0.05% of average loans.
Shareholders’ equity increased to $528.4 million, and tangible book value per share rose to $15.93. The company launched an at-the-market equity program for up to $50 million of common stock and declared a quarterly dividend on its 5.875% Series A preferred stock of $36.72 per share, or $0.3672 per depositary share, payable June 1, 2026 to holders of record on May 15, 2026.
Bridgewater Bancshares Inc director Mary Jayne Crocker exercised stock options to acquire 6,750 shares of Common Stock at an exercise price of $12.92 per share. Following the transaction, she directly holds 216,027 Common shares and retains options over 91,102 shares at $7.47 and 20,000 shares at $17.50, expiring in 2027 and 2032, respectively, granted under the company’s 2017 stock option plan.
Bridgewater Bancshares Inc director Mary Jayne Crocker exercised stock options to acquire 6,750 shares of Common Stock at an exercise price of $12.92 per share. Following the transaction, she directly holds 216,027 Common shares and retains options over 91,102 shares at $7.47 and 20,000 shares at $17.50, expiring in 2027 and 2032, respectively, granted under the company’s 2017 stock option plan.
Johnson James S. reported acquisition or exercise transactions in this Form 4 filing.
Bridgewater Bancshares Inc director James S. Johnson received a grant of 1,146 shares of Common Stock on March 31, 2026 as a compensation-related award at no stated price. Following this grant, he directly holds 96,494 shares of Common Stock.
In addition to his direct position, Johnson reports indirect holdings through various accounts. These include 59,250 shares held "By Trust" with Johnson as co-trustee of the James S. Johnson Trust, 76,750 shares held "By Trust" under the Jolynn Johnson Trust, and 10,417 shares held "By Spouse IRA," all as of the same date.
Johnson James S. reported acquisition or exercise transactions in this Form 4 filing.
Bridgewater Bancshares Inc director James S. Johnson received a grant of 1,146 shares of Common Stock on March 31, 2026 as a compensation-related award at no stated price. Following this grant, he directly holds 96,494 shares of Common Stock.
In addition to his direct position, Johnson reports indirect holdings through various accounts. These include 59,250 shares held "By Trust" with Johnson as co-trustee of the James S. Johnson Trust, 76,750 shares held "By Trust" under the Jolynn Johnson Trust, and 10,417 shares held "By Spouse IRA," all as of the same date.
Bridgewater Bancshares director Lisa Brezonik received a grant of 1,146 shares of Common Stock. The award was recorded at a price of $0.00 per share, indicating it was a compensation-related grant rather than an open-market purchase. Following this acquisition, Brezonik directly holds 36,219 shares of Bridgewater Bancshares common stock.
Bridgewater Bancshares director Lisa Brezonik received a grant of 1,146 shares of Common Stock. The award was recorded at a price of $0.00 per share, indicating it was a compensation-related grant rather than an open-market purchase. Following this acquisition, Brezonik directly holds 36,219 shares of Bridgewater Bancshares common stock.
Bridgewater Bancshares Inc director Mohammed Lawal received a grant of 1,146 shares of Common Stock as compensation. The shares were acquired at no cash cost to him and increase his direct holdings to 35,539 shares, indicating a routine, compensation-related equity award rather than an open-market purchase.
Bridgewater Bancshares Inc director Mohammed Lawal received a grant of 1,146 shares of Common Stock as compensation. The shares were acquired at no cash cost to him and increase his direct holdings to 35,539 shares, indicating a routine, compensation-related equity award rather than an open-market purchase.
Parish Douglas J. reported acquisition or exercise transactions in this Form 4 filing.
Bridgewater Bancshares Inc director Douglas J. Parish received a grant of 573 shares of Common Stock as compensation. The shares were awarded at a stated price of $0.00 per share, reflecting a stock-based grant rather than an open-market purchase.
After the grant, Parish directly holds 5,415 shares of Common Stock. In addition, 8,107 shares are held indirectly through the Douglas J Parish Revocable Trust, where he serves as co-trustee with shared voting and investment power over those trust-held shares.
Parish Douglas J. reported acquisition or exercise transactions in this Form 4 filing.
Bridgewater Bancshares Inc director Douglas J. Parish received a grant of 573 shares of Common Stock as compensation. The shares were awarded at a stated price of $0.00 per share, reflecting a stock-based grant rather than an open-market purchase.
After the grant, Parish directly holds 5,415 shares of Common Stock. In addition, 8,107 shares are held indirectly through the Douglas J Parish Revocable Trust, where he serves as co-trustee with shared voting and investment power over those trust-held shares.
Trutna Thomas P. reported acquisition or exercise transactions in this Form 4 filing.
Bridgewater Bancshares Inc director Thomas P. Trutna received a grant of 573 shares of Common Stock as compensation. The shares were awarded at a price of $0.00 per share, indicating they were not purchased on the open market. Following this award, Trutna directly holds 83,207 Bridgewater Bancshares shares.
Trutna Thomas P. reported acquisition or exercise transactions in this Form 4 filing.
Bridgewater Bancshares Inc director Thomas P. Trutna received a grant of 573 shares of Common Stock as compensation. The shares were awarded at a price of $0.00 per share, indicating they were not purchased on the open market. Following this award, Trutna directly holds 83,207 Bridgewater Bancshares shares.
Bridgewater Bancshares Inc director David J. Volk received a grant of 1,146 shares of Common Stock as compensation. The shares were acquired at a price of $0.00 per share, increasing his direct holdings to 32,284 shares. He also reports indirect ownership of 298 shares held by Volk Advisory Corp.
This filing reflects a grant, award, or other acquisition rather than an open-market purchase or sale, so it primarily updates his ownership position without signaling a discretionary trade.
Bridgewater Bancshares Inc director David J. Volk received a grant of 1,146 shares of Common Stock as compensation. The shares were acquired at a price of $0.00 per share, increasing his direct holdings to 32,284 shares. He also reports indirect ownership of 298 shares held by Volk Advisory Corp.
This filing reflects a grant, award, or other acquisition rather than an open-market purchase or sale, so it primarily updates his ownership position without signaling a discretionary trade.
Bridgewater Bancshares Inc director Mary Jayne Crocker received a grant of 280 shares of Common Stock as an award. The shares were acquired at a stated price of $0.00 per share, increasing her direct holdings to 209,277 shares following the transaction.
Bridgewater Bancshares Inc director Mary Jayne Crocker received a grant of 280 shares of Common Stock as an award. The shares were acquired at a stated price of $0.00 per share, increasing her direct holdings to 209,277 shares following the transaction.